Fresenius Medical Care AG Income Statement

Financials in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	19,628	19,336	19,454	19,398	17,619
Revenue Growth (YoY)	1.51%	-0.60%	0.29%	10.10%	-1.35%
Cost of Revenue	14,599	14,579	14,529	14,504	12,846
Gross Profit	5,029	4,757	4,925	4,894	4,773
Selling, General & Admin	3,033	3,143	3,196	3,170	2,773
Research & Development	157.98	183.49	231.97	228.62	220.78
Other Operating Expenses	-192.56	-172.82	-249.05	-197.7	-19.3
Total Operating Expenses	2,998	3,153	3,179	3,201	2,974
Operating Income	1,827	1,392	1,369	1,512	1,852
Interest Income	69.61	71.58	88.22	67.66	73.17
Interest Expense	-384.41	-407.04	-424.64	-360.14	-353.6
Other Non-Operating Income (Expense)	-	-	-	148.2	-
Total Non-Operating Income (Expense)	-314.8	-335.47	-336.42	-144.27	-280.43
Pretax Income	1,512	1,057	1,033	1,219	1,572
Provision for Income Taxes	320.97	316.06	300.56	324.95	352.83
Net Income	978.37	537.91	499	673.41	969.31
Minority Interest in Earnings	212.9	202.96	233.46	220.92	249.72
Net Income to Common	978.37	537.91	499	673.41	969.31
Net Income Growth	81.88%	7.80%	-25.90%	-30.53%	-16.75%
Shares Outstanding (Basic)	582	587	587	586	586
Shares Outstanding (Diluted)	582	587	587	586	586
Shares Change (YoY)	-0.76%	-	0.06%	0.10%	-0.38%
EPS (Basic)	1.68	0.92	0.85	1.15	1.66
EPS (Diluted)	1.68	0.92	0.85	1.15	1.66
EPS Growth	83.61%	7.65%	-26.09%	-30.51%	-16.41%
Free Cash Flow	1,766	1,687	1,944	1,443	1,635
Free Cash Flow Growth	4.67%	-13.24%	34.70%	-11.73%	-48.60%
Free Cash Flow Per Share	3.03	2.87	3.31	2.46	2.79
Dividends Per Share	1.490	1.440	1.190	1.120	1.350
Dividend Growth	3.47%	21.01%	6.25%	-17.04%	0.75%
Gross Margin	25.62%	24.60%	25.32%	25.23%	27.09%
Operating Margin	9.31%	7.20%	7.04%	7.79%	10.51%
Profit Margin	6.07%	3.83%	3.77%	4.61%	6.92%
FCF Margin	9.00%	8.72%	9.99%	7.44%	9.28%
EBITDA	3,327	3,135	3,121	3,350	3,476
EBITDA Margin	16.95%	16.21%	16.05%	17.27%	19.73%
EBIT	1,827	1,392	1,369	1,512	1,852
EBIT Margin	9.31%	7.20%	7.04%	7.79%	10.51%
Effective Tax Rate	21.22%	29.90%	29.10%	26.65%	22.45%

Updated Feb 24, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q